Trial intelligence / Profile preview

Carvedilol CR Add-on to Lisinopril in Type 2 Diabetes

NCT00430040Phase 4Terminated

Sponsor
University at Buffalo
Start
Feb 2007
Primary completion
May 2013
Countries
1
01

Overview

A Phase 4 trial of carvedilol in hypertension (HTN), sponsored by University at Buffalo. Started Feb 2007; status: terminated.

02

Drugs

carvedilol
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00430040.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00430040.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call